Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	76.41	133.25	75.53
Graham Fair Price	92.89	4365.99	2263.42
PEG	-95.46	0.02	0.44
Price/Book	-11.58	2.30	2.60
Price/Cash Flow	inf	0.00	66.38
Prices/Earnings	-73.14	5.03	18.73
Price/Sales	-5.89	14.07	14.95
Price/FCF	inf	0.00	66.38
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-29.73	0.20	0.28
Operating Margin	-83.88	0.02	0.12
ROA	227.23	0.05	0.01
ROE	0.03	0.11	229.26
ROIC	< 0.005	< 0.005	-86.94
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.02	< 0.005	-1252.10
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.13	-0.84	525.96
EPS QOQ	0.42	2.50	491.07
FCF QOQ	0.02	-1.00	6367.97
Revenue QOQ	-0.01	-0.01	4.84
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	23.47	22.16	-5.59
Days Sales Outstanding (DSO)	33.09	38.64	16.77
Inventory Turnover	3.83	4.06	5.92
Debt/Capitalization	0.46	0.43	-6.84
Quick Ratio	0.39	0.51	30.29
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2559.88	2721.25	6.30
Cash	269.86	497.65	84.41
Capex	0.00	0.00	0.00
Free Cash Flow	100.39	0.00	inf
Revenue	445.81	445.25	-0.12
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.55	0.64	16.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.08	28.45	66.59
Naive Interpretation	Member

06 - Financial Health · Bad

Rating